Cannabis comp tables as of Dec. 2, 2019
This comp table provides a benchmark for private investors to evaluate existing and future investments as well as a menu for public investors to peruse.
This comp table provides a benchmark for private investors to evaluate existing and future investments as well as a menu for public investors to peruse.
This comp table provides a benchmark for private investors to evaluate existing and future investments as well as a menu for public investors to peruse.
The week was busy with earnings misses and beats, legislative progress, contract and deal adjustments as well as reduced expectations.
This comp table provides a benchmark for private investors to evaluate existing and future investments as well as a menu for public investors to peruse.
As cannabis company fundamentals weaken and capital gets tighter, common equity investors need to recognize the possibility of major dilution from the equitization of debt that is due soon. This raises the cost of equity for any companies with debt.
This comp table provides a benchmark for private investors to evaluate existing and future investments as well as a menu for public investors to peruse.
The cannabis industry changes so rapidly that investors must always be aware of new information. This catalyst calendar provides you with key events that may impact your investments and investment decisions over the next month.
Portugal is gearing up to become a medical marijuana production powerhouse serving growing European markets.
This comp table provides a benchmark for private investors to evaluate existing and future investments as well as a menu for public investors to peruse.